Tremelimumab AstraZeneca
- Licence status
- Withdrawn: 29/04/2026
- Active substances
- Tremelimumab
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/22/1712/001-002
- Licence holder
- AstraZeneca AB
Product documents
Licence information
- ATC code
- L01FX20 tremelimumab, L01XC Monoclonal antibodies
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 20/02/2023